Clinical Trial Update: Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of PG324 ophthalmic solution for elevated intraocular pressure has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PG324 ophthalmic solution (PG324)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-06-04